Identification of potent 11mer Glucagon-Like Peptide-1 Receptor agonist peptides with novel C-terminal amino acids: Homohomophenylalanine analogs

Peptides

Volumn 31, Issue 5, 2010, Pages 950-955

  Haque, Tasir S ^a   Lee, Ving G ^a   Riexinger, Douglas ^a   Lei, Ming ^a   Malmstrom, Sarah ^a   Xin, Li ^a   Han, Songping ^a   Mapelli, Claudio ^a   Cooper, Christopher B ^a   Zhang, Ge ^a   Ewing, William R ^a   Krupinski, John ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Agonist; GLP 1R (Glucagon Like Peptide 1); Homohomophenylalanine

Indexed keywords

AMINO ACID; ANTIDIABETIC AGENT; CYCLIC AMP; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HOMOHOMOPHENYLALANINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG STRUCTURE; GLUCOSE TOLERANCE TEST; HAMSTER; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; OBESITY; OVARY CELL; PRIORITY JOURNAL; SOLID PHASE SYNTHESIS; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; AMINOBUTYRIC ACIDS; ANIMALS; BLOOD GLUCOSE; CHO CELLS; CRICETINAE; CRICETULUS; HYPERGLYCEMIA; MICE; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PEPTIDES; RECEPTORS, GLUCAGON;

EID: 77951254118     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.01.008     Document Type: Article

References (16)

1. Agerso H., Jensen L.B., Elbrond B., Rolan P., Zdravkovic M. The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new, long-acting GLP-1 derivative, in healthy men. Diabetologia 2002, 45:195-202.
2. Barlos K., Gatos D. 9-Fluorenylmethoxycarbonyl/t-butyl-based convergent protein synthesis. Biopolymers 1999, 51:266-278.
3. Bell G.I., Sanchez-Pescador R., Laybourn P.J., Najarian R.C. Exon duplication and divergence in the human preproglucagon gene. Nature 1983, 304:368-371.
4. Bell G.I., Santerre R.F., Mullenback G.T. Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 1983, 302:716-718.
5. Centers for Disease Control and Prevention National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007 2007, US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA, Available on the worldwide web at http://www.cdc.gov/diabetes/pubs/factsheet07.htm.
6. Collier P.N., Campbell A.D., Patel I., Taylor R.J.K. The direct synthesis of novel enantiomerically pure α-amino acids in protected form via Suzuki cross-coupling. Tetrahedron Lett 2000, 41:7115-7119.
7. Drucker D.J., Nauck M.A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006, 368:1696-1705.
8. Hoare S.R.J. Mechanisms of peptide and nonpeptide ligand binding to class B G-protein-coupled receptors. Drug Discov Today 2005, 10:417-427.
9. Krebs A., Ludwig V., Pfizer J., Dürner G., Göbel M.W. Enantioselective synthesis of non-natural aromatic α-amino acids. Chem Eur J 2004, 10:544-553.
10. Lenhard J.M., Gottschalk W.K. Preclinical developments in type 2 diabetes. Adv Drug Deliv Rev 2002, 54:1199-1212.
11. Lovshin J.A., Drucker D.J. Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol 2009, 5:262-269.
12. Mapelli C., Natarajan S., Meyer J.-P, Bastos M., Bernatowicz M., Lee V., et al. Eleven amino acid glucagon-like peptide-1 receptor agonists with antidiabetic activity. J Med Chem 2009, 52:7788-7799.
13. Nielsen L.L. Incretin mimetics and DPP-IV inhibitors for the treatment of type 2 diabetes. Drug Discov Today 2005, 10:703-710.
14. Perry T., Greig N.H. The glucagon-like peptides: a double-edged therapeutic sword?. Trends Pharmacol Sci 2003, 24:377-383.
15. Roges O.A., Baron M., Philis-Tsimikas A. The incretin effect and its potentiation by glucagon-like peptide 1-based therapies: a revolution in diabetes management. Expert Opin Investig Drugs 2005, 14:705-727.
16. Trivedi H.S., Anson M., Steel P.G., Worley J. A method for selective N-Boc deprotection on wang resin. Synlett 2001, 1932-1934.